The Cefoperazone–Sulbactam Combination: In Vitro Qualities Including Beta-Lactamase Stability, Antimicrobial Activity, and Interpretive Criteria for Disk Diffusion Tests
Abstract:Three concentrations of the penicillanic acid sulfone, sulbactam were tested in combination with cefoperazone against 632 recent clinical bacterial isolates. Cefoperazone was effective alone (less than or equal to 16 micrograms/mL) against 95% of Enterobacteriaceae and combined with 4 micrograms/mL sulbactam inhibited 99.5% of strains. This coverage of enteric bacilli was superior to timentin (99.1%), ceftazidime (98.2%), and tobramycin (90.9%). The minimum inhibitory concentrations (MICs) of cefoperazone-susc… Show more
“…Previous in vitro and in vivo studies of a -lactam antibiotic and sulbactam combination on bacteria producing ESBLs showed variable responses [6,7,11,[26][27][28][29][30][31][32][33][34]. In this study, piperacillin/sulbactam at a ratio of 2:1 significantly decreased the rate of ESBL-producing non-susceptible E. coli from 100% to 50% and decreased the MIC 50 from >128 mg/L to 16 mg/L compared with piperacillin alone.…”
“…Previous in vitro and in vivo studies of a -lactam antibiotic and sulbactam combination on bacteria producing ESBLs showed variable responses [6,7,11,[26][27][28][29][30][31][32][33][34]. In this study, piperacillin/sulbactam at a ratio of 2:1 significantly decreased the rate of ESBL-producing non-susceptible E. coli from 100% to 50% and decreased the MIC 50 from >128 mg/L to 16 mg/L compared with piperacillin alone.…”
“…The antibacterial eefect of Cep and a combined action of Cef + Sul individually has already been assessed in vitro and in vivo on bacteria producing ESBLs (Jones et al 1985;Drew et al 1998). The interest in using Sul as a suicide inhibitor lies in the fact that it is available independently of β-lactams.…”
The efficacy of the agents was evaluated on the basis of minimum inhibitory concentration (MIC) and time-kill curve analysis in Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii, Mycobacterium smegmatis, and Citrobacter braakii; MIC was found to be 0.5, 4.0, 0.015625, 0.0078125, and 0.0625 mg/L in FDC of ceftazidime + sulbactam, respectively, which is lower than ceftazidime and sulbactam individually. Time-kill curve analysis demonstrated maximum killing of bacteria after 4 h. A fixed dose combination of ceftazidime + sulbactam was found to have stronger antibacterial properties than ceftazidime and sulbactam alone at in vitro analysis.
“…In this procedure synergy is defined as a fourfold reduction in MIC for both components (107). Standard procedures for disk diffusion susceptibility testing have been outlined for Augmentin (a combination of 2 parts amoxicillin to 1 part clavulanic acid) (67), Timentin (a combination of 15 parts ticarcillin to 2 parts clavulanic acid) (66,78), cefoperazone-sulbactam (79), and ampicillin-sulbactam (17). However, a cautionary note has been reported, indicating that susceptibility test results may differ according to the medium used.…”
Section: Synergistic Activity Of Inhibitorsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.